ID: ALA2335930

Max Phase: Preclinical

Molecular Formula: C10H16N8

Molecular Weight: 248.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)Cn1cnc2c(NC(=N)N)nc(N)nc21

Standard InChI:  InChI=1S/C10H16N8/c1-5(2)3-18-4-14-6-7(15-9(11)12)16-10(13)17-8(6)18/h4-5H,3H2,1-2H3,(H6,11,12,13,15,16,17)

Standard InChI Key:  QVRDHSBJQFKSRS-UHFFFAOYSA-N

Associated Targets(Human)

Aurora kinase A/B 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 2/cyclin E1 1877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 1/cyclin B1 1887 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 248.29Molecular Weight (Monoisotopic): 248.1498AlogP: 0.37#Rotatable Bonds: 3
Polar Surface Area: 131.52Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.00CX LogP: 0.59CX LogD: -0.10
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.46Np Likeness Score: -0.82

References

1. Dolečková I, Cesnek M, Dračinský M, Brynda J, Voller J, Janeba Z, Kryštof V..  (2013)  Synthesis and biological evaluation of guanidino analogues of roscovitine.,  62  [PMID:23399722] [10.1016/j.ejmech.2013.01.021]

Source